Viome Life Sciences
$25.4M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Viome Life Sciences is currently valued at $415.4M as of August 27, 2024. The company has raised a total of $235.4M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.76x, Viome Life Sciences has achieved a valuation that is 1.76 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Viome Life Sciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Viome Life Sciences Worth in 2025?
As of 2025, Viome Life Sciences is valued at $415.4M, based on the company's Later Stage VC funding round in August 27, 2024. This valuation positions Viome Life Sciences as one of the leading private companies in the sector.
Viome Life Sciences Valuation History
Viome Life Sciences's funding history demonstrates steady growth and investor confidence.
How Viome Life Sciences Valuation is Determined
Private company valuations like Viome Life Sciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Viome Life Sciences Valuation FAQs
Is Viome Life Sciences profitable?
Viome Life Sciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Viome Life Sciences's valuation compare to competitors?
Viome Life Sciences is valued at $415.4M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Viome Life Sciences IPO?
Viome Life Sciences has not announced plans for an initial public offering. Until an IPO, investors can access Viome Life Sciences shares through secondary market platforms.